🩸 Prick. Dry. Detect: A Scalable Blood Test for Alzheimer's Pathology
Dr RR Baliga's "Got Knowledge Doc" Podkast
Audio is streamed directly from the publisher (traffic.libsyn.com) as published in their RSS feed. Play Podcasts does not host this file. Rights-holders can request removal through the copyright & takedown page.
Show Notes
🧠🩸 A finger-prick may change how we detect Alzheimer's disease.
A new Nature Medicine study shows that dried capillary blood spots can reliably measure key Alzheimer's biomarkers—p-tau217, GFAP, and neurofilament light—with strong concordance to venous plasma and cerebrospinal fluid results.
📊 In the DROP-AD multicenter study (7 sites, 337 participants), capillary p-tau217 correlated strongly with plasma (r≈0.74) and predicted amyloid pathology with good accuracy (AUC ≈0.86).
🚀 Why this matters:
• Enables minimally invasive, scalable, and potentially remote testing
• Expands access for population screening, prevention trials, and underserved groups (including Down syndrome)
• Moves us closer to earlier, equitable detection—though not yet ready for routine clinical decision-making
Small drop. Big signal. The future of Alzheimer's research may be at our fingertips. ✨